Gilead Sciences Inc. (GILD)
NASDAQ · Healthcare
Gilead Sciences Inc. Shareholder Equity 2007–2025
Gilead Sciences Inc. annual shareholder equity history from 2008 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Gilead Sciences Inc. shareholder equity as of December 31, 2025: 22.70B, a 17.45% increase year-over-year.
- Gilead Sciences Inc. shareholder equity for 2025 were 22.70B, a 17.45% increase from 2024.
- Gilead Sciences Inc. shareholder equity for 2024 were 19.33B, a 15.34% decrease from 2023.
- Gilead Sciences Inc. shareholder equity for 2023 were 22.83B, a 7.50% increase from 2022.
- Gilead Sciences Inc. shareholder equity for 2022 were 21.24B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Gilead Sciences Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $22,703 |
| 2024 | $19,330 |
| 2023 | $22,833 |
| 2022 | $21,240 |
| 2021 | $21,069 |
| 2020 | $18,202 |
| 2019 | $22,525 |
| 2018 | $21,387 |
| 2017 | $20,442 |
| 2016 | $18,887 |
| 2015 | $18,534 |
| 2014 | $15,426 |
| 2013 | $11,370 |
| 2012 | $9,303 |
| 2011 | $6,739 |
Gilead Sciences Inc. Shareholder Equity — FAQ
Gilead Sciences Inc. (GILD) shareholder equity over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GILD's shareholder equity history?
The chart and table above show Gilead Sciences Inc.'s shareholder equity by year and by quarter, including the growth rate.